+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Respiratory Syncytial Virus Vaccine for Children Market - Global Forecast 2026-2032- Product Image
Respiratory Syncytial Virus Vaccine for Children Market - Global Forecast 2026-2032- Product Image
Sale

Respiratory Syncytial Virus Vaccine for Children Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6081999
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Respiratory Syncytial Virus Vaccine for Children Market is projected to reach USD 1.22 Billion in 2026. It is expected to continue growing at a CAGR of 7.67%, reaching USD 1.90 Billion by 2032.

Introduction to Respiratory Syncytial Virus Vaccines for Children

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infection in infants and young children. Prevention strategies for pediatric RSV disease include maternal immunization during pregnancy, long-acting monoclonal antibodies for infants, and vaccines intended for specific pediatric age groups where regulatory authorities determine that benefits outweigh risks. Product eligibility, schedules, and recommendations differ by jurisdiction, so clinical use depends on age, medical risk, pregnancy status, seasonality, and national policy.

How Pediatric RSV Prevention Is Reshaping Respiratory Care

The prevention landscape is shifting from treatment of severe infection toward protection before exposure. Greater emphasis is being placed on seasonal planning, antenatal care, infant immunization pathways, hospital readiness, and equitable access for children at elevated risk. Regulatory agencies and public-health bodies continue to evaluate evidence on effectiveness, safety, duration of protection, and appropriate use across healthy infants and medically vulnerable children. These changes are also increasing the importance of coordinated procurement, cold-chain capacity, and clear communication with caregivers.

Artificial Intelligence’s Role in Pediatric RSV Prevention

Artificial intelligence can support pediatric RSV prevention by improving surveillance, identifying seasonal patterns, prioritizing outreach, and helping health systems match protection strategies with local disease burden. Machine-learning tools may also assist clinical research through participant identification, safety-signal review, and analysis of real-world outcomes. However, AI outputs require clinical validation, representative data, privacy safeguards, and human oversight. Bias in surveillance data or incomplete pediatric records could otherwise reinforce disparities in access or misclassify risk.

Regional Insights Across Global Pediatric RSV Prevention

In North America, prevention programs benefit from comparatively established pediatric and maternal health infrastructure, while implementation still depends on seasonal coordination and insurance or public-program coverage. Latin America is characterized by varied immunization capacity, uneven access between urban and rural populations, and the need to align prevention with maternal and child-health services. Europe combines strong regulatory and surveillance systems with differing national recommendations and reimbursement arrangements. The Middle East is shaped by substantial variation in health-system resources, migrant populations, and delivery conditions. Africa faces a high burden of childhood respiratory illness alongside constraints in diagnosis, cold-chain logistics, and access to preventive care. Asia-Pacific spans highly diverse health systems, from advanced national programs to settings where primary-care reach, affordability, and rural delivery remain central challenges.

Group-Level Priorities Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN countries must account for dense urban centers, cross-border movement, tropical and seasonal transmission patterns, and unequal access across member states. BRICS economies represent diverse disease burdens and health-system capacities, making local evidence and scalable delivery models important. The European Union benefits from coordinated scientific and regulatory collaboration, although national implementation and financing remain distinct. G7 members generally have strong surveillance and clinical infrastructure, with priorities centered on evidence quality, access, and protection of vulnerable children. GCC countries can leverage concentrated health services and coordinated procurement while addressing population mobility and heat-related operational constraints. NATO members, as a broad security community rather than a unified health program, have an interest in resilient supply chains, emergency preparedness, and continuity of pediatric services.

Country Priorities from Australia to the United States

Australia’s seasonal surveillance and geographically dispersed population make timing and rural delivery important. Brazil must address regional variation and access across its large public-health system. Canada’s geography and jurisdictional division require coordinated provincial and territorial implementation. China’s scale emphasizes surveillance, manufacturing resilience, and equitable pediatric access. France, Germany, Italy, and Spain must align national recommendations with European regulatory evidence and country-specific reimbursement pathways. India faces major differences in health access, birth-care settings, and diagnostic capacity. Japan and South Korea can build on advanced health systems while addressing demographic change and caregiver confidence. Mexico’s priorities include strengthening maternal-child health integration and reaching underserved communities. Russia’s geographically broad territory creates logistics and surveillance challenges. The United Kingdom must coordinate prevention policy across its devolved health systems. The United States combines substantial clinical capacity with complex coverage, delivery, and seasonal-planning requirements.

Actionable Priorities for Pediatric RSV Prevention Leaders

Industry and health-system leaders should first anchor decisions in age-specific evidence, regulatory guidance, and transparent safety monitoring. They should integrate RSV prevention with antenatal care, pediatric primary care, hospital discharge planning, and routine immunization workflows rather than creating isolated channels. Investments in cold-chain reliability, provider education, caregiver communication, and multilingual materials can improve uptake. Leaders should also establish real-world evidence programs that track hospitalization, breakthrough disease, safety, and access across socioeconomic and geographic groups. Responsible AI deployment should include validated models, privacy controls, bias testing, and clinician review. Finally, procurement and supply planning should account for seasonal surges, rural delivery, and continuity during emergencies.

Research Methodology for the Pediatric RSV Vaccine Assessment

This executive summary applies a structured review of publicly available evidence from authoritative regulatory, public-health, clinical, and scientific sources. The assessment considers pediatric RSV epidemiology, prevention modalities, clinical guidance, safety and effectiveness evidence, delivery infrastructure, regional health-system conditions, and policy implementation factors. Regional, group, and country observations are synthesized qualitatively from established demographic, epidemiological, and health-service characteristics. Findings are separated from areas of uncertainty, and no unsupported commercial estimates, market sizing, market shares, or forecasts are used.

Conclusion: Building Equitable Pediatric RSV Protection

Pediatric RSV prevention is moving toward earlier, more coordinated protection of infants and children, supported by maternal health services, immunization infrastructure, surveillance, and evidence-based policy. The central challenge is not only scientific development but also dependable delivery across different geographies, health systems, and risk groups. Leaders that combine rigorous safety monitoring with practical access planning, caregiver trust, resilient supply chains, and responsible data use will be better positioned to reduce severe RSV disease while supporting equitable protection for children.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Respiratory Syncytial Virus Vaccine for Children Market, by Vaccine Type
7.1. Introduction
7.2. Live Attenuated Vaccine
7.3. Monoclonal Antibody
7.4. mRNA Vaccine
7.5. Subunit Vaccine
7.5.1. Protein Subunit
7.5.2. Virus Like Particle
7.6. Vector Based Vaccine
8. Respiratory Syncytial Virus Vaccine for Children Market, by Age Group
8.1. Introduction
8.2. 0 To 6 Months
8.2.1. Full Term Infants
8.2.2. Preterm Infants
8.3. 12 To 24 Months
8.4. 6 To 12 Months
9. Respiratory Syncytial Virus Vaccine for Children Market, by Dose Regimen
9.1. Introduction
9.2. Multi Dose
9.2.1. Three Dose Series
9.2.2. Two Dose Series
9.3. Single Dose
10. Respiratory Syncytial Virus Vaccine for Children Market, by Distribution Channel
10.1. Introduction
10.2. Clinic Pharmacies
10.3. Hospital Pharmacies
10.4. Online Pharmacies
10.5. Retail Pharmacies
11. Respiratory Syncytial Virus Vaccine for Children Market, by End User
11.1. Introduction
11.2. Ambulatory Care Centers
11.3. Clinics
11.4. Hospitals
11.4.1. Private Hospitals
11.4.2. Public Hospitals
12. Respiratory Syncytial Virus Vaccine for Children Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Respiratory Syncytial Virus Vaccine for Children Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Respiratory Syncytial Virus Vaccine for Children Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AstraZeneca plc
16.2. Bavarian Nordic A/S
16.3. BioNTech SE
16.4. CureVac N.V.
16.5. GlaxoSmithKline plc
16.6. Janssen Pharmaceuticals, Inc.
16.7. Meissa Vaccines, Inc.
16.8. Moderna, Inc.
16.9. Pfizer Inc.
16.10. Sanofi S.A.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Respiratory Syncytial Virus Vaccine for Children Market, Years Considered for the Study
FIGURE 2. Global Respiratory Syncytial Virus Vaccine for Children Market, Research Design
FIGURE 3. Global Respiratory Syncytial Virus Vaccine for Children Market, Research Framework
FIGURE 4. Global Respiratory Syncytial Virus Vaccine for Children Market, Data Triangulation
FIGURE 5. Global Respiratory Syncytial Virus Vaccine for Children Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2025 vs 2032 (%)
FIGURE 7. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2025 vs 2032 (%)
FIGURE 9. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2025 vs 2032 (%)
FIGURE 11. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Respiratory Syncytial Virus Vaccine for Children Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Respiratory Syncytial Virus Vaccine for Children Market Segmentation & Coverage
TABLE 2. Global Respiratory Syncytial Virus Vaccine for Children Market Size, 2017-2032 (USD Million)
TABLE 3. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 4. Global Live Attenuated Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Live Attenuated Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Live Attenuated Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Monoclonal Antibody Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Monoclonal Antibody Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Monoclonal Antibody Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global mRNA Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global mRNA Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global mRNA Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Subunit Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Subunit Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Subunit Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Protein Subunit Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Protein Subunit Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Protein Subunit Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Virus Like Particle Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Virus Like Particle Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Virus Like Particle Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Vector Based Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Vector Based Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Vector Based Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 26. Global 0 To 6 Months Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global 0 To 6 Months Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global 0 To 6 Months Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Full Term Infants Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Full Term Infants Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Full Term Infants Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Preterm Infants Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Preterm Infants Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Preterm Infants Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global 12 To 24 Months Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global 12 To 24 Months Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global 12 To 24 Months Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global 6 To 12 Months Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global 6 To 12 Months Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global 6 To 12 Months Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 42. Global Multi Dose Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Multi Dose Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Multi Dose Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Three Dose Series Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Three Dose Series Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Three Dose Series Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Two Dose Series Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Two Dose Series Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Two Dose Series Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Single Dose Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Single Dose Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Single Dose Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 55. Global Clinic Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Clinic Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Clinic Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. Global Ambulatory Care Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Ambulatory Care Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Ambulatory Care Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Respiratory Syncytial Virus Vaccine for Children Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 94. North America Respiratory Syncytial Virus Vaccine for Children Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. North America Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 96. North America Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 97. North America Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 98. North America Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 99. North America Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 100. North America Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 101. North America Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 102. North America Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. North America Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 104. Latin America Respiratory Syncytial Virus Vaccine for Children Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Latin America Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 106. Latin America Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 107. Latin America Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 108. Latin America Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 109. Latin America Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 110. Latin America Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 111. Latin America Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 112. Latin America Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. Latin America Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 114. Europe Respiratory Syncytial Virus Vaccine for Children Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Europe Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 116. Europe Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 117. Europe Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 118. Europe Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 119. Europe Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 120. Europe Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 121. Europe Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 122. Europe Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. Europe Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 124. Middle East Respiratory Syncytial Virus Vaccine for Children Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Middle East Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 126. Middle East Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 127. Middle East Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 128. Middle East Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 129. Middle East Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 130. Middle East Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 131. Middle East Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 132. Middle East Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Middle East Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 134. Africa Respiratory Syncytial Virus Vaccine for Children Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Africa Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 136. Africa Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 137. Africa Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 138. Africa Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 139. Africa Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 140. Africa Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 141. Africa Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 142. Africa Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. Africa Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 144. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. ASEAN Respiratory Syncytial Virus Vaccine for Children Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. ASEAN Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 147. ASEAN Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 148. ASEAN Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 149. ASEAN Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 150. ASEAN Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 151. ASEAN Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 152. ASEAN Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 153. ASEAN Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. ASEAN Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 155. GCC Respiratory Syncytial Virus Vaccine for Children Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. GCC Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 157. GCC Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 158. GCC Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 159. GCC Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 160. GCC Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 161. GCC Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 162. GCC Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 163. GCC Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. GCC Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 165. European Union Respiratory Syncytial Virus Vaccine for Children Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. European Union Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 167. European Union Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 168. European Union Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 169. European Union Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 170. European Union Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 171. European Union Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 172. European Union Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 173. European Union Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. European Union Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 175. BRICS Respiratory Syncytial Virus Vaccine for Children Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. BRICS Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 177. BRICS Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 178. BRICS Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 179. BRICS Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 180. BRICS Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 181. BRICS Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 182. BRICS Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 183. BRICS Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. BRICS Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 185. G7 Respiratory Syncytial Virus Vaccine for Children Market Size, by Group, 2017-2032 (USD Million)
TABLE 186. G7 Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 187. G7 Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 188. G7 Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 189. G7 Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 190. G7 Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 191. G7 Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 192. G7 Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 193. G7 Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. G7 Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 195. NATO Respiratory Syncytial Virus Vaccine for Children Market Size, by Group, 2017-2032 (USD Million)
TABLE 196. NATO Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 197. NATO Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 198. NATO Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 199. NATO Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 200. NATO Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 201. NATO Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 202. NATO Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 203. NATO Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. NATO Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 205. Global Respiratory Syncytial Virus Vaccine for Children Market Size, by Country, 2017-2032 (USD Million)
TABLE 206. United States Respiratory Syncytial Virus Vaccine for Children Market Size, 2017-2032 (USD Million)
TABLE 207. United States Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 208. United States Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 209. United States Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 210. United States Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 211. United States Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 212. United States Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 213. United States Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 214. United States Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. United States Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 216. Canada Respiratory Syncytial Virus Vaccine for Children Market Size, 2017-2032 (USD Million)
TABLE 217. Canada Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 218. Canada Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 219. Canada Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 220. Canada Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 221. Canada Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 222. Canada Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 223. Canada Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 224. Canada Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. Canada Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 226. Mexico Respiratory Syncytial Virus Vaccine for Children Market Size, 2017-2032 (USD Million)
TABLE 227. Mexico Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 228. Mexico Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 229. Mexico Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 230. Mexico Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 231. Mexico Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 232. Mexico Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 233. Mexico Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 234. Mexico Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. Mexico Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 236. Brazil Respiratory Syncytial Virus Vaccine for Children Market Size, 2017-2032 (USD Million)
TABLE 237. Brazil Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 238. Brazil Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 239. Brazil Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 240. Brazil Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 241. Brazil Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 242. Brazil Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 243. Brazil Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 244. Brazil Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. Brazil Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 246. United Kingdom Respiratory Syncytial Virus Vaccine for Children Market Size, 2017-2032 (USD Million)
TABLE 247. United Kingdom Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 248. United Kingdom Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 249. United Kingdom Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 250. United Kingdom Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 251. United Kingdom Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 252. United Kingdom Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 253. United Kingdom Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 254. United Kingdom Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 255. United Kingdom Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 256. Germany Respiratory Syncytial Virus Vaccine for Children Market Size, 2017-2032 (USD Million)
TABLE 257. Germany Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 258. Germany Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 259. Germany Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 260. Germany Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 261. Germany Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 262. Germany Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 263. Germany Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 264. Germany Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. Germany Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 266. France Respiratory Syncytial Virus Vaccine for Children Market Size, 2017-2032 (USD Million)
TABLE 267. France Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 268. France Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 269. France Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 270. France Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 271. France Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 272. France Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 273. France Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 274. France Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. France Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 276. Russia Respiratory Syncytial Virus Vaccine for Children Market Size, 2017-2032 (USD Million)
TABLE 277. Russia Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 278. Russia Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 279. Russia Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 280. Russia Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 281. Russia Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 282. Russia Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 283. Russia Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 284. Russia Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. Russia Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 286. Italy Respiratory Syncytial Virus Vaccine for Children Market Size, 2017-2032 (USD Million)
TABLE 287. Italy Respiratory Syncytial Virus Vaccine for Children Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 288. Italy Respiratory Syncytial Virus Vaccine for Children Market Size, by Subunit Vaccine, 2017-2032 (USD Million)
TABLE 289. Italy Respiratory Syncytial Virus Vaccine for Children Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 290. Italy Respiratory Syncytial Virus Vaccine for Children Market Size, by 0 To 6 Months, 2017-2032 (USD Million)
TABLE 291. Italy Respiratory Syncytial Virus Vaccine for Children Market Size, by Dose Regimen, 2017-2032 (USD Million)
TABLE 292. Italy Respiratory Syncytial Virus Vaccine for Children Market Size, by Multi Dose, 2017-2032 (USD Million)
TABLE 293. Italy Respiratory Syncytial Virus Vaccine for Children Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 294. Italy Respiratory Syncytial Virus Vaccine for Children Market Size, by End User, 2017-2032 (USD Million)
TABLE 295. Italy Respiratory Syncytial Virus Vaccine for Children Market Size, by Hospi

Companies Mentioned

  • AstraZeneca plc
  • Bavarian Nordic A/S
  • BioNTech SE
  • CureVac N.V.
  • GlaxoSmithKline plc
  • Janssen Pharmaceuticals, Inc.
  • Meissa Vaccines, Inc.
  • Moderna, Inc.
  • Pfizer Inc.
  • Sanofi S.A.

Related Topics

Related Reports

Respiratory Syncytial Virus Vaccine for the Elderly Market - Global Forecast 2026-2032 - Product Image

Respiratory Syncytial Virus Vaccine for the Elderly Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Respiratory Syncytial Virus Vaccine Global Market Opportunities and Strategies to 2035 - Product Image

Respiratory Syncytial Virus Vaccine Global Market Opportunities and Strategies to 2035

  • Report
  • 296 Pages
  • Global
From
Respiratory Syncytial Virus Vaccine Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Respiratory Syncytial Virus Vaccine Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 250 Pages
  • Global
From
Respiratory Syncytial Virus Therapeutic Drugs Market - Global Forecast 2026-2032 - Product Image

Respiratory Syncytial Virus Therapeutic Drugs Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Human Respiratory Syncytial Virus Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Human Respiratory Syncytial Virus Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 117 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.